DE69706988D1 - Verfahren zur lieferung von zusammensetzungen aus dichten teilchen zur anwendung in transdermale teilchen abgabe - Google Patents

Verfahren zur lieferung von zusammensetzungen aus dichten teilchen zur anwendung in transdermale teilchen abgabe

Info

Publication number
DE69706988D1
DE69706988D1 DE69706988T DE69706988T DE69706988D1 DE 69706988 D1 DE69706988 D1 DE 69706988D1 DE 69706988 T DE69706988 T DE 69706988T DE 69706988 T DE69706988 T DE 69706988T DE 69706988 D1 DE69706988 D1 DE 69706988D1
Authority
DE
Germany
Prior art keywords
particle delivery
densified
dense particles
delivering compositions
transdermal particle
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69706988T
Other languages
English (en)
Other versions
DE69706988T2 (de
Inventor
Francis Sarphie
Lee Burkoth
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Powderject Research Ltd
Original Assignee
Powderject Research Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Powderject Research Ltd filed Critical Powderject Research Ltd
Application granted granted Critical
Publication of DE69706988D1 publication Critical patent/DE69706988D1/de
Publication of DE69706988T2 publication Critical patent/DE69706988T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2/00—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic
    • B01J2/22—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic by pressing in moulds or between rollers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/89—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microinjection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
DE69706988T 1996-06-17 1997-06-17 Verfahren zur lieferung von zusammensetzungen aus dichten teilchen zur anwendung in transdermale teilchen abgabe Expired - Fee Related DE69706988T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9612629.7A GB9612629D0 (en) 1996-06-17 1996-06-17 Method for providing dense particle compositions for use in transdermal particle delivery
PCT/GB1997/001636 WO1997048485A1 (en) 1996-06-17 1997-06-17 Method for providing dense particle compositions for use in transdermal particle delivery

Publications (2)

Publication Number Publication Date
DE69706988D1 true DE69706988D1 (de) 2001-10-31
DE69706988T2 DE69706988T2 (de) 2002-04-04

Family

ID=10795416

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69706988T Expired - Fee Related DE69706988T2 (de) 1996-06-17 1997-06-17 Verfahren zur lieferung von zusammensetzungen aus dichten teilchen zur anwendung in transdermale teilchen abgabe

Country Status (11)

Country Link
EP (1) EP0912239B1 (de)
JP (1) JP2000513338A (de)
AT (1) ATE206067T1 (de)
AU (1) AU3102597A (de)
CA (1) CA2258554C (de)
DE (1) DE69706988T2 (de)
DK (1) DK0912239T3 (de)
ES (1) ES2164348T3 (de)
GB (1) GB9612629D0 (de)
PT (1) PT912239E (de)
WO (1) WO1997048485A1 (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7223739B1 (en) 1995-06-07 2007-05-29 Powderject Vaccines, Inc. Adjuvanted genetic vaccines
GB9619002D0 (en) * 1996-09-11 1996-10-23 Oxford Biosciences Ltd Particle delivery
GB9819272D0 (en) * 1998-09-03 1998-10-28 Andaris Ltd Microparticles
US6558961B1 (en) * 1998-09-04 2003-05-06 Powderject Research Limited Immunodiagnostics using particle delivery methods
PT1117382E (pt) * 1998-10-01 2005-08-31 Powderject Res Ltd Microparticulas revestidas por pulverizacao para utilizacao em seringas sem agulha
US6881723B1 (en) 1998-11-05 2005-04-19 Powderject Vaccines, Inc. Nucleic acid constructs
WO2000043058A1 (en) * 1999-01-22 2000-07-27 Powderject Research Limited Method of enhancing needleless transdermal powdered drug delivery
PT1146861E (pt) 1999-02-03 2005-10-31 Powderject Res Ltd Formulacoes de particulas de hidrogel
AU3593200A (en) 1999-02-09 2000-08-29 Powderject Vaccines, Inc. (mycobacterium tuberculosis), immunization
CA2364198A1 (en) * 1999-03-08 2000-09-14 Powderject Research Limited Delivery of microparticle formulations using needleless syringe device for sustained-release of bioactive compounds
US6190701B1 (en) 1999-03-17 2001-02-20 Peter M. Ronai Composition and method for stable injectable liquids
ATE285806T1 (de) 1999-10-11 2005-01-15 Felton International Inc Universelle antiinfektionsschutzvorrichtung für nadellose injektoren
US7196066B1 (en) 1999-11-03 2007-03-27 Powderject Vaccines, Inc. DNA-vaccines based on constructs derived from the genomes of human and animal pathogens
US7887506B1 (en) 1999-11-23 2011-02-15 Pulse Needlefree Systems, Inc. Safety mechanism to prevent accidental patient injection and methods of same
AU2001297988B2 (en) 2000-11-27 2006-10-26 Powderject Vaccines, Inc. Nucleic acid adjuvants
GB0103620D0 (en) * 2001-02-14 2001-03-28 Prometic Biosciences Ltd Sterile composition and its preparation
CA2449593A1 (en) 2001-06-08 2002-12-19 Powderject Vaccines, Inc. Spray freeze-dried compositions
US7383084B2 (en) 2002-10-31 2008-06-03 Transpharma Medical Ltd. Transdermal delivery system for dried particulate or lyophilized medications
IL152574A (en) * 2002-10-31 2009-09-22 Transpharma Medical Ltd A system for passing through the skin of dry items or dried medicines
US7662404B2 (en) 2002-10-31 2010-02-16 Transpharma Medical Ltd. Transdermal delivery system for dried particulate or lyophilized peptides and polypeptides
US8133505B2 (en) 2002-10-31 2012-03-13 Transpharma Medical Ltd. Transdermal delivery system for dried particulate or lyophilized medications
CA2702340C (en) 2006-10-12 2014-12-16 The University Of Queensland Compositions and methods for modulating immune responses
US20110212096A1 (en) 2006-12-01 2011-09-01 Scott Rollins Anti-p-selectin antibodies and methods of their use and identification
US8945565B2 (en) 2006-12-01 2015-02-03 Selexys Pharmaceuticals Corporation Methods of treating inflammatory or thrombotic conditions with anti-P-selectin antibodies
PL2662091T3 (pl) 2006-12-01 2019-05-31 Novartis Ag Przeciwciała skierowane przeciwko selektynie P i sposoby ich zastosowania do leczenia chorób zapalnych
LT2712622T (lt) 2008-05-21 2016-09-26 Ferring B.V. Burnoje disperguojamas desmopresinas, skirtas nikturijos netrikdomo miego pirminio periodo pailginimui
US20100286045A1 (en) 2008-05-21 2010-11-11 Bjarke Mirner Klein Methods comprising desmopressin
US11963995B2 (en) 2008-05-21 2024-04-23 Ferring B.V. Methods comprising desmopressin
DE102009002826A1 (de) * 2009-05-05 2010-11-11 Beiersdorf Ag Nadelfreies Injektionssystem zur kosmetischen Wirkstoffapplikation
ES2362525B8 (es) 2009-10-08 2013-01-03 Azurebio, S.L. Formulación de medicamentos en forma de agujas percutaneas penetrantes.
EP2635596B8 (de) 2010-11-01 2020-03-11 University of Technology Sydney Immunmodulierende mittel und verwendungen dafür
WO2013138871A1 (en) 2012-03-23 2013-09-26 The University Of Queensland Immunomodulatory agent and uses therefor
ES2781433T3 (es) 2016-02-23 2020-09-02 Merck Patent Gmbh Partículas de glicina, así como procedimiento para su preparación y su uso

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4018037A1 (de) * 1990-02-10 1991-08-14 Peroxid Chemie Gmbh Verfahren zur herstellung von peroxoborat-agglomeraten
US5147291A (en) * 1990-06-11 1992-09-15 Cukier A David Sound transmission apparatus for uniformly administering chemical composition through the skin

Also Published As

Publication number Publication date
DE69706988T2 (de) 2002-04-04
AU3102597A (en) 1998-01-07
ES2164348T3 (es) 2002-02-16
CA2258554C (en) 2006-08-15
EP0912239B1 (de) 2001-09-26
DK0912239T3 (da) 2001-11-19
CA2258554A1 (en) 1997-12-24
JP2000513338A (ja) 2000-10-10
WO1997048485A1 (en) 1997-12-24
GB9612629D0 (en) 1996-08-21
PT912239E (pt) 2002-03-28
ATE206067T1 (de) 2001-10-15
EP0912239A1 (de) 1999-05-06

Similar Documents

Publication Publication Date Title
DE69706988D1 (de) Verfahren zur lieferung von zusammensetzungen aus dichten teilchen zur anwendung in transdermale teilchen abgabe
EE9700176A (et) Kuivpulbriinhalaatorites kasutatav pulber, selle valmistamismeetod, selles kasutatavad osakesed ja meetod nende valmistamiseks ning pulbri lisandi kasutamine
ATE312600T1 (de) Verfahren und system zur behandlung dispergierbarer feiner pulver
DE59209244D1 (de) Inhalationspulver und verfahren zu ihrer herstellung
DE60030721D1 (de) Pulverpartikel mit glatter oberfläche zur verwendung in der inhalationstherapie
DE69725308D1 (de) Verfahren und vorrichtung zur inhalation teilchenförmiger medikamente
RS50495B (sr) Postupak za pripremanje preparata u obliku praha
ATE202713T1 (de) Werkstoff als ausgangsmaterial zur herstellung von knochenzement, verfahren zu seiner herstellung, und verfahren zur herstellung von knochenzement
ATE152573T1 (de) Protein mit zeitverabreichung
ATE241958T1 (de) Mahlverfahren zur herstellung feingemahlener medizinischer substanzen
IL142276A0 (en) Spray coated microparticles for use in needleless syringes
FR2587989B1 (fr) Compositions particulaires d'oxalates de metaux ferromagnetiques, sous forme de particules aciculaires submicroniques, leur preparation et leur application
GB2396627A (en) Composites comprising superabsorbent materials having a bimodal particle size distribution and methods of making the same
AU3844995A (en) Implantable device for administration of active substances to plants
DE69408122T2 (de) Zusammensetzung aus mikropartikeln in verdichteter phase und verfahren
PL1518551T3 (pl) Stała postać dawki zawierająca kofeinę

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee